Live attenuated human rotavirus vaccine 89-12 data

Researchers presented data from a placebo-controlled Phase I/II trial of the vaccine in 117 infants at the Infectious Diseases Society of America meeting in San Francisco. They concluded that the vaccine was safe, but that as with other rotavirus vaccines, reactogenicity increased with age. ...